Literature DB >> 19393900

Effect of partial and full correction of corneal spherical aberration on visual acuity and contrast sensitivity.

Teresa Ferrer-Blasco1.   

Abstract

A 60-year-old white man had cataract surgery with an AcrySof IQ intraocular lens (IOL) implanted in the right eye and a Tecnis IOL implanted in the left eye. The ocular spherical aberration (SA) target for a 6.0 mm pupil was +0.10 microm for the right eye and 0 microm for the left eye. After surgery, the ocular SA in the right eye was significantly higher than that in the left eye (+0.112 microm +/- 0.002 [SD] versus +0.021 +/- 0.003 microm; P<.001). No between-eye difference in the best corrected visual acuity and photopic contrast sensitivity was found. The contrast sensitivity was significantly better in the eye with the AcrySof IQ IOL at 12 and 18 cpd under mesopic conditions. The best contrast sensitivity was achieved in the eye with a residual ocular SA of about +0.10 microm.

Entities:  

Mesh:

Year:  2009        PMID: 19393900     DOI: 10.1016/j.jcrs.2008.12.041

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Higher order aberration comparison between two aspherical intraocular lenses: MC6125AS and Akreos advanced optics.

Authors:  Mohammad Taher Rajabi; Sara Korouji; Mahgol Farjadnia; Mohammad Naderan; Mohammad Bagher Rajabi; Bahram Khosravi; Seyed Mehdi Tabatabaie
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

2.  Analysis of Corneal Spherical Aberrations in Cataract Patients with High Myopia.

Authors:  Min Zhang; Dongjin Qian; Qinghe Jing; Jiahui Chen; Yongxiang Jiang
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

3.  Correlations of Corneal Spherical Aberration with Astigmatism and Axial Length in Cataract Patients.

Authors:  Min Zhang; Dongjin Qian; Qinghe Jing; Jiahui Chen; Michael Deng; Yongxiang Jiang
Journal:  J Ophthalmol       Date:  2019-09-10       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.